31.58
-0.01
(-0.03%)
At close: January 31 at 4:00:00 PM EST
31.35
-0.23
(-0.73%)
After hours: 7:23:35 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
2,799,089.00
2,987,802.00
2,143,980.00
2,017,536.00
2,034,629.00
Investing Cash Flow
-3,172,699.00
-2,072,789.00
-1,029,421.00
-1,870,280.00
-2,759,320.00
Financing Cash Flow
387,214.00
-2,148,754.00
-944,856.00
385,112.00
1,487,172.00
End Cash Position
950,052.00
477,010.00
1,710,751.00
1,541,048.00
1,008,680.00
Issuance of Capital Stock
--
--
--
--
1,908,744.00
Issuance of Debt
1,821,235.00
350,000.00
--
1,272,533.00
11,891,030.00
Repayment of Debt
-350,000.00
-1,350,000.00
--
--
-11,210,396.00
Repurchase of Capital Stock
-207,244.00
-304,759.00
--
--
--
Free Cash Flow
2,799,089.00
2,987,802.00
2,143,980.00
2,017,536.00
2,034,629.00
12/31/2020 - 6/16/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
TNYA Tenaya Therapeutics, Inc.
1.0600
0.00%
CYTK Cytokinetics, Incorporated
49.46
-1.02%
BBIO BridgeBio Pharma, Inc.
34.21
-4.89%
ROIV Roivant Sciences Ltd.
11.13
-2.11%
GMAB Genmab A/S
19.67
-0.71%
ARGX argenx SE
655.13
-1.58%
INCY Incyte Corporation
74.16
+0.53%
ETNB 89bio, Inc.
9.60
-0.41%
RVMD Revolution Medicines, Inc.
42.95
-0.28%
VTYX Ventyx Biosciences, Inc.
2.0100
-1.95%